$HBAN

Why is Huntington Bancshares stock sliding today?

Huntington Bancshares (HBAN) stock fell 2.0% to $16.41 in pre-market trading after lowering its fiscal 2027 EPS guidance to $1.75-$1.83, down from $1.90-$1.93, and revising 2026 net interest income growth forecast lower. The bank cited high short-term rates and deposit pricing competition. The stock's ex-dividend date is September 17.

Original reporting
Published Sep 16, 2026, 12:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 12:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HBAN
Bearish
high confidence
Mentioned
$HBAN
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HBANBearishHigh
01

Why it matters

The downward revision of earnings guidance reflects pressure on net interest margins, prompting a 2% pre‑market decline and setting the tone for broader regional‑bank sentiment.

02

Market read

Guidance cut is a primary catalyst for HBAN's price move and may influence peer banks in the sector.

03

What to watch

Upcoming ex‑dividend date and conference exposure could temporarily boost liquidity despite the guidance cut.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Huntington Bancshares (HBAN) is a Columbus‑based regional bank whose earnings are sensitive to interest‑rate dynamics and competitive deposit pricing.

Company-level read

Ticker impact

$HBANBearishHigh confidence
Context

HBAN cut FY2027 EPS guidance to $1.75‑$1.83 (down from $1.90‑$1.93) and lowered 2026 net interest income growth, sending the stock 2% lower in pre‑market trading.

Expected impact

Further downside of 3‑5% intraday as investors reassess margin outlook.

Evidence & confidence

The guidance cut is a fresh, material disclosure for a regional bank; market reaction already shows a 2% drop, indicating sensitivity.

Market effects

Regional banks may face heightened scrutiny on margin outlook, potentially pressuring peers.

Midwest banking stocks could see modest sell‑offs in early trading.

Limited to U.S. banking sector; no direct global impact.

Counterpoint

If the bank can stabilize net interest margins, the price dip may present a buying opportunity at a discount.

Key entities

  • Huntington Bancshares Inc.

    Regional bank issuing the guidance cut.

  • Steve Steinour

    CEO presenting at the Barclays Global Financial Services Conference.

Related articles

$HBANMed

Stocks fall after Federal Reserve raises interest rates

U.S. stocks fell Wednesday after the Federal Reserve raised interest rates, with the S&P 500 down 0.4% and the Dow Jones dropping 1.2%. Fed Chairman Kevin Warsh indicated more hikes may come as inflation remains high. Traders expect rates to reach 4.25%-4.50% by year-end. Bank stocks declined, while AI-related stocks like Nvidia and AMD rose.

$JPMMed

Major US banks raise prime rate after first Fed rate hike since 2023

Top U.S. banks, including JPMorgan and Bank of America, raised their prime lending rate to 7% after the Federal Reserve's first rate hike since 2023. The Fed increased rates by 0.25% and signaled further hikes, aiming to combat inflation. Bank shares fell, with JPMorgan down 1% and Goldman Sachs down 4%. Higher rates boost bank earnings but may slow economic activity and reduce loan demand.

$HBANMed

HBAN Looks 0.2% Undervalued on GF Value™ as Dividend Sustainabil

Huntington Bancshares (HBAN) promoted Brant Standridge to president, potentially positioning him as a future CEO. The company offers a 3.73% dividend yield with a 42% payout ratio, and its stock is fairly valued at $16.62 vs. GF Value™ of $16.66. HBAN has a GF Score™ of 79, with strengths in growth and valuation but weaker financial strength. Insiders have sold more shares than purchased, and institutional investors show mixed sentiment.

$HBANMed

Huntington Bancshares Q2 Earnings Call Highlights

Huntington Bancshares management said it is on track for $365 million in Cadence cost synergies in Q4 and $435 million in combined Veritex and Cadence run-rate expense synergies by Q4. Q2 average loans rose $15B (8.6%) and deposits rose $18.8B (9.2%). Net interest income was $2.1B (+8.5%); value-added fees rose over 60% YoY. Outlook: NII pressured by deposit costs; EPS target for 2027 is $1.90 to $1.93.